Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
point of care
Abridge secures $250M for core research and development
By
Anthony Vecchione
|
02:25 pm |
February 17, 2025
The company will use the funds to enhance the development of its AI capabilities and for commercial growth.